Azitra, Inc.

AMEX (USD): Azitra, Inc. (AZTR)

Last Price

0.417

Today's Change

+0.019 (4.77%)

Day's Change

0.35 - 0.433

Trading Volume

3,746,419

Overview

Market Cap

3 Million

Shares Outstanding

7 Million

Avg Volume

6,947,610

Avg Price (50 Days)

0.38

Avg Price (200 Days)

1.72

PE Ratio

0.00

EPS

-111.24

Earnings Announcement

14-Mar-2025

Previous Close

0.40

Open

0.36

Day's Range

0.35 - 0.433

Year Range

0.233 - 12.0

Trading Volume

3,795,668

Price Change Highlight

1 Day Change

4.70%

5 Day Change

14.45%

1 Month Change

54.91%

3 Month Change

-8.62%

6 Month Change

-33.86%

Ytd Change

-6.32%

1 Year Change

-94.46%

3 Year Change

-99.72%

5 Year Change

-99.72%

10 Year Change

-99.72%

Max Change

-99.72%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment